New Delhi: In the wake of multi-drug resistant (MDR)-TB cases increasing in India, Union Health Minister Harsh Vardhan today launched India's first National Anti-Tuberculosis Drug Resistance Survey, 2014-2015.
The survey will be conducted on 5,214 patients across the country and will provide information on the prevalence of anti-tuberculosis drug resistance among the new and already undergoing treatment patients.
"It often happens that patients who have TB disease stop taking the drugs soon after they start feeling better. They can become sick again as if the drugs are not taken correctly, the TB bacteria may still remain alive and the person may become resistant to those drugs and will have to then given second-line drugs," said Mr Vardhan.
Multi-drug-resistant TB (MDR-TB) is resistant to two or more of the first-line drugs used to treat the disease.
The number of multi-drug resistant (MDR)-TB cases in the country had increased five-fold between 2011 and 2013. Studies show one-third of the MDR-TB cases are resistant to fluoroquinolones, which are critical for MDR-TB treatment.
The survey programme will include tracking the effectiveness of TB prevention and control activities, design standardized regimens for the treatment of drug-resistant TB, assess epidemiological trends and identify and respond to outbreaks of drug-resistant TB.
The survey will be conducted on 5,214 patients across the country and will provide information on the prevalence of anti-tuberculosis drug resistance among the new and already undergoing treatment patients.
"It often happens that patients who have TB disease stop taking the drugs soon after they start feeling better. They can become sick again as if the drugs are not taken correctly, the TB bacteria may still remain alive and the person may become resistant to those drugs and will have to then given second-line drugs," said Mr Vardhan.
Multi-drug-resistant TB (MDR-TB) is resistant to two or more of the first-line drugs used to treat the disease.
Advertisement
The number of multi-drug resistant (MDR)-TB cases in the country had increased five-fold between 2011 and 2013. Studies show one-third of the MDR-TB cases are resistant to fluoroquinolones, which are critical for MDR-TB treatment.
Advertisement
The survey programme will include tracking the effectiveness of TB prevention and control activities, design standardized regimens for the treatment of drug-resistant TB, assess epidemiological trends and identify and respond to outbreaks of drug-resistant TB.
Advertisement
COMMENTS
Advertisement
"Doctors Must Work Without Fear": Medical Body Chief Over Kolkata Horror Kerala Health Minister Meets With Accident En Route To Wayanad Cancer Cases Rising, Prices Of Essential Medicines Kept In Check: Health Minister Who Is Jasveen Sangha, "Ketamine Queen" Charged With Matthew Perry's Death Mamata Banerjee To Take Out Rally Over Rape-Murder. Trinamool Explains Why "Don't Expect Anything From Me": Kolkata Hospital's New Principal Loses Cool UCC To Corruption, 4 Messages From Modi's Independence Day Speech What ISRO's 'Baby Rocket' Launch Means For India's Future In Space Pakistan Reports 1st M-Pox Case As Saudi Arabia Returnee Tests Positive Track Latest News Live on NDTV.com and get news updates from India and around the world.